Since GATA3 IHC is currently used in routine diagnostic practice as a surrogate marker for breast and urothelial origins of carcinomas of unknown primary, this should be straightforward, however, standardized methods with a univocal and reproducible cutoff are needed. This evidence concerns the gene GATA3 and carcinoma.